1. Home
  2. ARQT vs XHR Comparison

ARQT vs XHR Comparison

Compare ARQT & XHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • XHR
  • Stock Information
  • Founded
  • ARQT 2016
  • XHR 2007
  • Country
  • ARQT United States
  • XHR United States
  • Employees
  • ARQT N/A
  • XHR N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • XHR Real Estate Investment Trusts
  • Sector
  • ARQT Health Care
  • XHR Real Estate
  • Exchange
  • ARQT Nasdaq
  • XHR Nasdaq
  • Market Cap
  • ARQT 1.6B
  • XHR 1.5B
  • IPO Year
  • ARQT 2020
  • XHR N/A
  • Fundamental
  • Price
  • ARQT $13.52
  • XHR $11.52
  • Analyst Decision
  • ARQT Strong Buy
  • XHR Hold
  • Analyst Count
  • ARQT 6
  • XHR 5
  • Target Price
  • ARQT $18.80
  • XHR $13.50
  • AVG Volume (30 Days)
  • ARQT 2.1M
  • XHR 911.5K
  • Earning Date
  • ARQT 05-06-2025
  • XHR 05-02-2025
  • Dividend Yield
  • ARQT N/A
  • XHR 4.87%
  • EPS Growth
  • ARQT N/A
  • XHR 16.62
  • EPS
  • ARQT N/A
  • XHR 0.22
  • Revenue
  • ARQT $212,819,000.00
  • XHR $1,060,486,000.00
  • Revenue This Year
  • ARQT $57.99
  • XHR $3.36
  • Revenue Next Year
  • ARQT $41.24
  • XHR $3.63
  • P/E Ratio
  • ARQT N/A
  • XHR $51.57
  • Revenue Growth
  • ARQT 100.03
  • XHR 3.57
  • 52 Week Low
  • ARQT $6.99
  • XHR $8.55
  • 52 Week High
  • ARQT $17.75
  • XHR $16.50
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 42.59
  • XHR 58.93
  • Support Level
  • ARQT $12.42
  • XHR $11.15
  • Resistance Level
  • ARQT $15.67
  • XHR $11.87
  • Average True Range (ATR)
  • ARQT 0.87
  • XHR 0.39
  • MACD
  • ARQT -0.03
  • XHR 0.23
  • Stochastic Oscillator
  • ARQT 33.69
  • XHR 84.38

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About XHR Xenia Hotels & Resorts Inc.

Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other. Xenia's revenue is divided between room, food and beverage, and other. The room segment contributes to the vast majority of the firm's total revenue. The firm's customer groups include transient business, group business, and contract business.

Share on Social Networks: